Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Sen. Glenn medical radiation hearing

This article was originally published in The Gray Sheet

Executive Summary

Sen. John Glenn's (D-Ohio) Governmental Affairs Committee postpones hearing on regulation of medical radiation by FDA and the Nuclear Regulatory Commission. The hearing, originally scheduled for April 22 ("The Gray Sheet" March 22, p. 4), is tentatively slated for late May. FDA Center for Devices and Radiological Health Director Bruce Burlington will give testimony on behalf of FDA. NRC commissioners and members of the National Conference of Radiation Control Program Directors also are expected to testify.

You may also be interested in...



Pipeline Watch: Phase III Readouts In Ischemic Stroke, Atopic Dermatitis

Pipeline Watch is a weekly snapshot of selected late-stage clinical trial events and approvals announced by pharmaceutical and biotech companies at medical and industry conferences, in financial and company presentations, and in company releases and statements.

 

Beximco And Mylan Strike Biosimilars Deal

Bangladesh’s Beximco will market Mylan’s biosimilars in its domestic market, under a deal that has just been struck between the two companies. The Ogivri trastuzumab biosimilar, co-developed by Mylan and Biocon, will be the first product launched as part of the collaboration.

GSK Offloads Physiogel In North America, Asia To Korea’s LG

GSK will raise around £125m from the sale of skin-care brand Physiogel to LG Household & Healthcare to finance the integration of Pfizer Consumer Healthcare. 
UsernamePublicRestriction

Register

MT000544

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel